About Technology Issues FAQ

Links

The TEL-AML1 real-time quantitative polymerase chain reaction (PCR) might replace the antigen receptor-based genomic PCR in clinical minimal residual disease studies  in children with acute lymphoblastic leukaemia

The TEL-AML1 real-time quantitative polymerase chain reaction (PCR) might replace the antigen receptor-based genomic PCR in clinical minimal residual disease studies  in children with acute lymphoblastic leukaemia — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.